Correlation Between Takeda Pharmaceutical and Greater Cannabis

Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Greater Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Greater Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Takeda Pharmaceutical Co and Greater Cannabis, you can compare the effects of market volatilities on Takeda Pharmaceutical and Greater Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Greater Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Greater Cannabis.

Diversification Opportunities for Takeda Pharmaceutical and Greater Cannabis

0.02

Correlation Coefficient

Takeda Pharmaceutical  Greater Cannabis

Significant diversification

The 3 months correlation between Takeda and Greater is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Greater Cannabis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Greater Cannabis and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Greater Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Greater Cannabis has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Greater Cannabis go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Greater Cannabis

Considering the 90-day investment horizon Takeda Pharmaceutical is expected to generate 19.65 times less return on investment than Greater Cannabis. But when comparing it to its historical volatility, Takeda Pharmaceutical Co is 13.41 times less risky than Greater Cannabis. It trades about 0.08 of its potential returns per unit of risk. Greater Cannabis is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  0.05  in Greater Cannabis on November 29, 2024 and sell it today you would earn a total of  0.03  from holding Greater Cannabis or generate 60.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Takeda Pharmaceutical Co  vs.  Greater Cannabis

Takeda Pharmaceutical

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Takeda Pharmaceutical Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Greater Cannabis

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Greater Cannabis are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Greater Cannabis displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Takeda Pharmaceutical and Greater Cannabis

The main advantage of trading using opposite Takeda Pharmaceutical and Greater Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Greater Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Greater Cannabis will offset losses from the drop in Greater Cannabis' long position.

The idea behind Takeda Pharmaceutical Co and Greater Cannabis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.